Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgen insensitivity syndrome

M N Patterson1, M J McPhaul, I A Hughes

  • 1Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, UK.

Bailliere'S Clinical Endocrinology and Metabolism
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GDF15 linked to maternal risk of nausea and vomiting during pregnancy.

Nature·2023
Same author

Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy.

bioRxiv : the preprint server for biology·2023
Same author

Lipid ratios representing SCD1, FADS1, and FADS2 activities as candidate biomarkers of early growth and adiposity.

EBioMedicine·2021
Same author

Which infancy growth parameters are associated with later adiposity? The Cambridge Baby Growth Study.

Annals of human biology·2020
Same author

Maternal serum concentrations of bisphenol A and propyl paraben in early pregnancy are associated with male infant genital development.

Human reproduction (Oxford, England)·2020
Same author

Associations between a fetal imprinted gene allele score and late pregnancy maternal glucose concentrations.

Diabetes & metabolism·2017
Same journal

Phytoestrogen content in foods.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Experimental studies on lignans and cancer.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Reproductive actions of phytoestrogens.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and inhibition of angiogenesis.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and diseases of the prostate gland.

Bailliere's clinical endocrinology and metabolism·1999
See all related articles

Androgen insensitivity syndromes (AIS) are better understood due to advances in genetics and molecular biology. Identifying androgen receptor gene mutations helps explain varied patient symptoms and guides genetic counseling, though challenges remain.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Understanding of androgen insensitivity syndromes (AIS) has rapidly advanced.
  • Interdisciplinary approaches combining endocrinology, genetics, and molecular biology have been crucial.

Purpose of the Study:

  • To correlate androgen receptor gene mutations with the clinical presentation of AIS.
  • To explore the potential for novel treatment strategies and improved genetic counseling for AIS patients.
  • To address remaining challenges in understanding AIS, including testicular malignancy risk and phenotype variability.

Main Methods:

  • Identification of mutations in the androgen receptor gene in suspected AIS cases.
  • In-vitro functional examination of identified mutations.

Related Experiment Videos

  • Correlation of genetic findings with patient clinical presentation.

    • Main Results:

    • Genetic and molecular biology insights are beginning to explain the variable clinical presentations of AIS.
    • Mutation identification facilitates precise genetic counseling for families affected by AIS.
    • Functional studies offer speculative avenues for novel treatment strategies.

    Conclusions:

    • Significant progress has been made in understanding the molecular causes of AIS.
    • Further research is needed to address remaining clinical challenges, such as the risk of testicular malignancy and the factors contributing to phenotype variability.
    • Understanding androgen receptor gene mutations is key for diagnosis, counseling, and potential future therapies.